BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 25536866)

  • 21. Insulin Pumps.
    Pickup JC
    Diabetes Technol Ther; 2017 Feb; 19(S1):S19-S26. PubMed ID: 28192024
    [No Abstract]   [Full Text] [Related]  

  • 22. Managing type 2 diabetes: going beyond glycemic control.
    Stolar MW; Hoogwerf BJ; Gorshow SM; Boyle PJ; Wales DO
    J Manag Care Pharm; 2008 Jun; 14(5 Suppl B):s2-19. PubMed ID: 18597582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Achieving glycemic goals with addition of incretin-based therapies to insulin in patients with type 2 diabetes mellitus.
    Tibaldi J
    Am J Med Sci; 2014 Jun; 347(6):491-501. PubMed ID: 24469234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin glargine for type 2 diabetes.
    Hemraj F; Garces K
    Issues Emerg Health Technol; 2004 Aug; (59):1-4. PubMed ID: 15311441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower severe hypoglycemia risk: insulin glargine versus NPH insulin in type 2 diabetes.
    Dailey G; Strange P
    Am J Manag Care; 2008 Jan; 14(1):25-30. PubMed ID: 18197742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An interprofessional qualitative study of barriers and potential solutions for the safe use of insulin in the hospital setting.
    Rousseau MP; Beauchesne MF; Naud AS; Leblond J; Cossette B; Lanthier L; Grondin F; Bernier F
    Can J Diabetes; 2014 Apr; 38(2):85-9. PubMed ID: 24690502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin therapy for challenging patient cases.
    Shubrook JH
    J Am Osteopath Assoc; 2013 Apr; 113(4 Suppl 2):S17-28. PubMed ID: 23545887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Hypoglycemia in Cardiovascular Outcomes in Diabetes.
    Paty BW
    Can J Diabetes; 2015 Dec; 39 Suppl 5():S155-9. PubMed ID: 26654859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.
    Casagrande S; Cowie CC; Fradkin JE
    J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Benefits and harms of intensive glycemic control in patients with type 2 diabetes.
    Rodriguez-Gutierrez R; Gonzalez-Gonzalez JG; Zuñiga-Hernandez JA; McCoy RG
    BMJ; 2019 Nov; 367():l5887. PubMed ID: 31690574
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fasting hyperglycemia: etiology, diagnosis, and treatment.
    Sheehan JP
    Diabetes Technol Ther; 2004 Aug; 6(4):525-33. PubMed ID: 15321011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiation and Titration of Basal Insulin in Primary Care: Barriers and Practical Solutions.
    Perreault L; Vincent L; Neumiller JJ; Santos-Cavaiola T
    J Am Board Fam Med; 2019; 32(3):431-447. PubMed ID: 31068410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin therapy for type 2 diabetes.
    Swinnen SG; Hoekstra JB; DeVries JH
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S253-9. PubMed ID: 19875560
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin therapy for type 2 diabetes.
    Meneghini LF
    Endocrine; 2013 Jun; 43(3):529-34. PubMed ID: 23104148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH; Verchere CB
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
    [No Abstract]   [Full Text] [Related]  

  • 39. Early insulin: an important therapeutic strategy.
    Dailey GE
    Diabetes Care; 2005 Jan; 28(1):220-1. PubMed ID: 15616256
    [No Abstract]   [Full Text] [Related]  

  • 40. HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups.
    Sidorenkov G; van Boven JFM; Hoekstra T; Nijpels G; Hoogenberg K; Denig P
    Diabetes Obes Metab; 2018 Aug; 20(8):1957-1964. PubMed ID: 29687577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.